Notice is given under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), of the following application to register a trade name product under section 9(1) of the Act:

Trade Name: Daxocox

Reference: A012186

Active Ingredients and Concentrations:

Each tablet contains Enflicoxib [15/30/45/70/100/140/200] mg

Formulation Type: Tablet

Application method/administration route: Oral

General Use Claim:

For the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

Any person may make a written submission to the Director-General concerning this application.

Under sections 16 and 17 of the Act, a written submission:

1. must state in full the reasons for making the submission;
2. may state any decision sought on that application; and
3. must be received by the Director-General no later than 30 working days after the date of this notice.

Each submission must state the trade name product(s) to which it relates. Under section 18 of the Act, a copy of every submission will be forwarded to the applicant.

The following address is:

1. where submissions on this application are to be sent;
2. where requests for copies of the public information relating to the application can be sent;
3. where public information relating to the application can be viewed; and
4. the Director-General’s address for service:

ACVM Team, Ministry for Primary Industries, Charles Fergusson Building, 38–42 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.

MPI encourages submission by email.

The applicant’s address for service is:

Virbac New Zealand Limited, 26–30 Maui Street, Pukete, Hamilton 3200. Postal Address: Virbac New Zealand Limited, PO Box 10305, Te Rapa, Hamilton 3241.

Dated at Wellington this 3rd day of June 2025.

SHALEEN NARAYAN, Manager Approvals, Ministry for Primary Industries (Acting under delegated authority).